These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15369200)

  • 1. Combating substance abuse with ibogaine: pre- and posttreatment recommendations and an example of successive model fitting analyses.
    Hittner JB; Quello SB
    J Psychoactive Drugs; 2004 Jun; 36(2):191-9. PubMed ID: 15369200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibogaine in the treatment of substance dependence.
    Brown TK
    Curr Drug Abuse Rev; 2013 Mar; 6(1):3-16. PubMed ID: 23627782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication development of ibogaine as a pharmacotherapy for drug dependence.
    Mash DC; Kovera CA; Buck BE; Norenberg MD; Shapshak P; Hearn WL; Sanchez-Ramos J
    Ann N Y Acad Sci; 1998 May; 844():274-92. PubMed ID: 9668685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of antiaddictive actions of ibogaine.
    Glick SD; Maisonneuve IS
    Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review.
    Maciulaitis R; Kontrimaviciute V; Bressolle FM; Briedis V
    Hum Exp Toxicol; 2008 Mar; 27(3):181-94. PubMed ID: 18650249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.
    Corkery JM
    Prog Brain Res; 2018; 242():217-257. PubMed ID: 30471681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures.
    Mash DC; Kovera CA; Pablo J; Tyndale RF; Ervin FD; Williams IC; Singleton EG; Mayor M
    Ann N Y Acad Sci; 2000 Sep; 914():394-401. PubMed ID: 11085338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ibogaine medical subculture.
    Alper KR; Lotsof HS; Kaplan CD
    J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How toxic is ibogaine?
    Litjens RP; Brunt TM
    Clin Toxicol (Phila); 2016; 54(4):297-302. PubMed ID: 26807959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ibogaine - structure, influence on human body, clinical relevance].
    Zdrojewicz Z; Kuszczak B; Olszak N
    Pol Merkur Lekarski; 2016 Jul; 41(241):50-55. PubMed ID: 27734823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-addiction drug ibogaine and the heart: a delicate relation.
    Koenig X; Hilber K
    Molecules; 2015 Jan; 20(2):2208-28. PubMed ID: 25642835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga.
    Paškulin R; Jamnik P; Danevčič T; Koželj G; Krašovec R; Krstić-Milošević D; Blagojević D; Strukelj B
    J Ethnopharmacol; 2012 Aug; 143(1):319-24. PubMed ID: 22751004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating drug dependence with the aid of ibogaine: a retrospective study.
    Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX
    J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction.
    Maas U; Strubelt S
    Med Hypotheses; 2006; 67(4):960-4. PubMed ID: 16698188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of memory retrieval by the "anti-addictive" alkaloid, ibogaine.
    Popik P
    Life Sci; 1996; 59(24):PL379-85. PubMed ID: 8950313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.
    Noller GE; Frampton CM; Yazar-Klosinski B
    Am J Drug Alcohol Abuse; 2018; 44(1):37-46. PubMed ID: 28402682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].
    Kazlauskas S; Kontrimaviciūte V; Sveikata A
    Medicina (Kaunas); 2004; 40(3):216-9. PubMed ID: 15064541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DARK Classics in Chemical Neuroscience: Ibogaine.
    Wasko MJ; Witt-Enderby PA; Surratt CK
    ACS Chem Neurosci; 2018 Oct; 9(10):2475-2483. PubMed ID: 30216039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Ibogaine on Uterine Smooth Muscle Contractions: Relation to the Activity of Antioxidant Enzymes.
    Oreščanin-Dušić Z; Tatalović N; Vidonja-Uzelac T; Nestorov J; Nikolić-Kokić A; Mijušković A; Spasić M; Paškulin R; Bresjanac M; Blagojević D
    Oxid Med Cell Longev; 2018; 2018():5969486. PubMed ID: 29599898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iboga interactions with psychomotor stimulants: panacea in the paradox?
    Szumlinski KK; Maisonneuve IM; Glick SD
    Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.